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Transfer of regulatory T cells into 
abortion-prone mice promotes the 
expansion of uterine mast cells 
and normalizes early pregnancy 
angiogenesis
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Implantation of the fertilized egg depends on the coordinated interplay of cells and molecules that 
prepare the uterus for this important event. In particular, regulatory T cells (Tregs) are key regulators 
as their ablation hinders implantation by rendering the uterus hostile for the embryo. In addition, the 
adoptive transfer of Tregs can avoid early abortion in mouse models. However, it is still not defined 
which mechanisms underlie Treg function during this early period. Cells of the innate immune system 
have been reported to support implantation, in part by promoting angiogenesis. In particular, uterine 
mast cells (uMCs) emerge as novel players at the fetal-maternal interface. Here, we studied whether 
the positive action of Tregs is based on the expansion of uMCs and the promotion of angiogenesis. 
We observed that abortion-prone mice have insufficient numbers of uMCs that could be corrected 
by the adoptive transfer of Tregs. This in turn positively influenced the remodeling of spiral arteries 
and placenta development as well as the levels of soluble fms-like tyrosine kinase 1 (sFlt-1). Our data 
suggest an interplay between Tregs and uMCs that is relevant for the changes required at the feto-
maternal interface for the normal development of pregnancy.
After the egg is fertilized, the uterus prepares for implantation. Genetic factors are relevant for the qual-
ity and viability of the blastocyst; however complex interactions between the immune system and the 
endocrine system are necessary for an adequate environment where the embryo is able to grow. For 
implantation to be successful, it is necessary to have a healthy uterine milieu that allows the invasion of 
the blastocyst and the rapid growth of the placenta while supporting the transformation of uterine into 
decidual cells. This is mediated and facilitated by immune cell populations, the cytokines they secrete 
and by hormonal changes. Innate immune cells of importance for implantation are present already before 
pregnancy. They usually present a unique phenotype that greatly differs from the phenotype of their 
counterparts located in the periphery or in other tissues. Among the innate immune cells, the most 
intensively studied are the uterine natural killer cells (uNKs)1. They contribute to angiogenesis and to 
the remodeling of spiral arteries (SAs)1,2. Uterine dendritic cells (uDCs) are present in high numbers 
at specific sites along the non-pregnant uterus as shown in vivo3 and are important for implantation4,5. 
Uterine mast cells (uMCs) also differ enormously from MCs found in other tissues and are involved 
in implantation6,7. Especially MC-associated proteases (Mcpt), including tryptases and chymases, are 
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involved in uMC function8. Uterine macrophages directly communicate with trophoblasts in a bidirec-
tional way9. They are in charge of maintaining the luteal microvascular network that is necessary for 
the integrity of the corpus luteum and progesterone production10. A recently described population of 
second-trimester decidual neutrophils shows a unique phenotype and possesses angiogenic properties11. 
From this information, a picture emerges, where cells of the innate immune system are responsible for 
the changes necessary to support pregnancy, namely the promotion of angiogenesis and tissue remode-
ling. An imbalance in cell number or abnormal distribution can cause suboptimal angiogenesis, which is 
often related to pregnancy complications. Elevated levels of the anti-angiogenic factor placental soluble 
fms-like tyrosine kinase 1 (sFlt-1) has been linked to endothelial dysfunction that in turn causes hyper-
tension and proteinuria in preeclampsia12. Angiotensin Receptor II (AT2) seems to be of relevance as well 
as it is involved in cardiovascular functions during pregnancy13.
Already at copulation, the female´s immune system gets in contact with male antigens present in 
sperm; animal studies as well as studies performed with samples from patients immediately after coi-
tus indicate that seminal fluid rapidly attracts cells from the innate and adaptive immune system14,15. 
Thus, the maternal immune system is aware very early of the presence of foreign, paternal antigens. 
Animals lacking T and B cells can get pregnant and have progeny16, so that at the first glance it could 
be inferred that adaptive immune cells are not absolutely necessary for pregnancy. Studies in the last 
years, however, have shown that a small subtype of adaptive CD4+ T cells is necessary for implantation. 
The depletion of CD4+Foxp3+ regulatory T cells (Tregs) before mating drastically influences the uterine 
environment and hampers the implantation of the fetus17, while depletion at later time points only pro-
vokes a mild augmentation in the abortion rate18. Hence, it is of central importance to understand the 
local mechanisms governing the implantation of the embryo. Here, we used a well-established model 
in which disturbed pregnancy tolerance can be restored by the addition of Tregs before implantation19. 
With this model, we aimed to elucidate whether Treg transfer activates uMCs and positively influences 
angiogenesis. Various studies suggest a direct interaction between MCs and Tregs. It could be demon-
strated that MCs are critical in Treg-mediated allograft tolerance and that Tregs activate and recruit MCs 
via IL-920,21. The suppression of MC degranulation by Tregs can dampen allergic MC responses, and 
in vivo depletion of Tregs provokes MC-related anaphylactic symptoms22,23. Furthermore, MC-derived 
IL-2 supports Treg-mediated suppression during allergic dermatitis24 and MC-derived transforming 
growth factor (TGF-) β is able to induce the conversion of naïve T cells into Tregs in vitro25. We are 
particulary interested in the interplay between Tregs and MCs as MCs are not only present in the female 
reproductive tract26–28 but also migrate from the periphery to the uterus upon female hormone augmen-
tation29. When pregnancy occurs, uMC numbers further increase and remain high during early gesta-
tion6. uMCs have a positive influence on placentation and the remodeling of SAs as well as on placenta 
size and fetal growth. MCs are multifaceted cells that interact with other immune and non-immune 
cells. Whether Treg/MCs communication or interplay is of relevance for pregnancy establishment and 
maintenance was not explored and is the main aim of this study.
Results
uMC numbers peak during sexual receptivity and remain high if pregnancy takes place in 
normal but not in abortion-prone mice. We first quantified the numbers of MCs in Toluidine blue-
stained slides of uteri from CBA/J mice and observed an oscillation in uMC numbers at the different 
phases of the estrous cycle (Fig. 1a). The number of uMCs peaked at estrus, which represents the period 
of sexual receptivity. We next studied the mRNA transcripts for molecules that are stored in MC granula 
and secreted upon activation. mRNA levels of the Mcpt-1, Mcpt-6 and Carboxypeptidase A3 (Cpa3) 
were significantly elevated at the metestrus phase (Fig. 1b–d). This is interesting as this phase follows the 
estrus, showing that MC-related proteases augment immediately after the peak of MC numbers, which 
suggests their local activation followed by the secretion of mediators upon degranulation. This in turn 
coincides with the time point at which the uterus undergoes degenerative modifications.
We next studied the localization and numbers of uMCs during early pregnancy. For that, we ana-
lyzed samples from BALB/c-mated CBA/J females known to have normal pregnancies (NP) and from 
DBA/2J-mated CBA/J females that have reportedly augmented abortion rates (abortion-prone group, 
AP) due to impaired feto-maternal tolerance19. We did so at days 0, 2 and 5 of pregnancy. We observed 
that in NP females at all three time points, uMC numbers were even higher than at estrus (Fig.  1a,e). 
Astonishingly, this was not the case for females from the AP group whose uMC levels were comparable 
to the ones observed during metestrus (Fig. 1a,e). As for their localization, uMCs were located in close 
proximity to the developing embryo as shown in Fig. 1f.
Adoptive transfer of Tregs diminishes the occurrence of fetal death, which is associated with 
an augmentation of uMCs. We next employed a well-characterized strategy to rescue fetuses from 
abortion in the CBA/J × DBA/2J combination, which consists in adoptively transferring antigen-specific 
Tregs immediately after plug detection19,30,31. We confirmed that Treg-transferred females have fewer 
abortions than the PBS-treated controls and this was comparable with the abortion rate observed in NP 
animals (Fig. 2a,b). This was associated with augmented CD4+Foxp3+ Treg numbers in decidua (Fig. 2c), 
but also in thymus (Fig. 2d) and spleen (Fig. 2e). To evaluate whether Treg transfer has an impact on MC 
numbers, we studied reproductive tissues as well as the spleen and lymph nodes. The adoptive transfer of 
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Tregs was associated with an augmentation in the proportion of CD117+Fcε RIα + double positive MCs 
cells in the decidua, the maternal part of the fetal-maternal interface (Fig. 2f), in the oviduct (Fig. 2g) 
and in splenic tissue (Fig.  2h) compared to AP mice that were sham-treated. Interestingly, the Treg 
transfer normalized MC numbers to the levels observed in NP individuals (Fig. 2f–h). In lymph nodes, 
the MC number remained unchanged (data not shown). Accordingly to the elevated MC numbers, 
Mcpt-1 mRNA levels in the decidua of AP mice increased after Treg transfer (Fig. 2i). IL-9 mRNA was 
almost indetectable at the feto-maternal interface but IL-3 and mSCF mRNA were both augmented after 
Treg transfer (Suppl. Fig. 1). As both factors were proposed to be growth factors for mast cells, it is pos-
sible that Treg directly or indirectly augment the levels of both, finally resulting in augmented numbers 
of uMCs in situ. Blockage of IL-10, identified as the main Treg mediator in this particular model30, not 
only abrogated the protective effect of Tregs (see material and methods) but also hindered Mcpt-1 mRNA 
levels augmentation (Suppl. Fig. 2). As isolation and further culture of uMCs is technically challenging, 
a final confirmation of functional changes in uMCs remains open, but the augmentation of Mcpt-1 after 
Treg transfer and its lack of augmentation when the main Treg mediator was blocked strongly suggest 
that Treg transfer influences not only MC numbers but also their activity.
Placental development and SA remodeling are impaired in abortion-prone mice and restored 
by the transfer of Tregs. Next, we studied the placentation and SA remodeling in abortion-prone 
females. Because MC numbers directly correlate with the remodeling of SAs6, we asked whether Treg 
transfer into abortion-prone females could improve placentation and pregnancy outcome via the upreg-
ulation of MC numbers. Placental surface areas were decreased in AP mice, where both Tregs and MCs 
Figure 1. Number of uMCs peaks at sexual receptivity and uMCs expand with the onset of pregnancy. 
Abortion-prone mice have diminished uMC numbers. (a) Number of uMCs per 1 mm2 was quantified 
in Tolouidine blue stained paraffin sections (5 μ m) from uteri of virgin CBA/J females (n = 6–8) during 
different phases of the estrous cycle. The mRNA levels of MC-related proteases Mcpt-1 (b), Mcpt-6 (c) 
and Cpa3 (d) were measured in uterine tissue of virgin CBA females at proestrus, estrus, metestrus or 
diestrus. (e) uMCs number per 1 mm2 was quantified in uterine paraffin sections (5 μ m) of BALB/c-paired 
CBA/J females (normal pregnant, NP) or DBA/2-mated CBA/J females (abortion-prone, AP) at gestational 
days (gd) 0, 2 and 5 of pregnancy. (f) During pregnancy MCs are localized in the decidua between the 
implantation sites. MCs (magnification × 100) were visualized after Toluidine blue O staining (0.1%) at days 
2 and 5 of pregnancy in NP and AP mice and are indicated by circles. For (a,e) the results are presented as 
single values with means. Statistical differences were obtained using unpaired t- test (*p < 0.054, **p < 0.005, 
***p < 0.001). For (b–d) the results are presented as individual values plus medians. Statistical differences 
were obtained using non-parametric Mann-Whitney-U- test (*p < 0.054, **p < 0.005).
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were present in lower numbers as in NP mice (Fig. 3a,b). This was accompanied by insufficiently remod-
eled SAs, characterized by an increased wall thickness (Fig. 3c) that resulted in abnormal wall to lumen 
ratios (Fig. 3d) when compared with NP mice. AP mice showed high SA wall expression of smooth mus-
cle actin and coherently arranged multilayered smooth muscle cells, signs of impaired SA remodeling 
(Fig. 3e). Adoptive Treg transfer into AP mice completely normalized the shaping of the SAs and resulted 
in normal placental surface areas; both were comparable to those observed in NP mice (Fig. 3a–e).
Abortion-prone mice show enhanced expression of placental sFlt-1 and AT2, which is reduced 
by Treg transfer. We next studied the sFlt-1 and AT2 expression in placental tissue of AP mice that 
presented diminished numbers of Tregs and MCs (Fig. 2c–h), smaller placental areas and impaired SA 
modification (Fig. 3a–e). In placentas from AP mice sFlt-1 was significantly higher expressed when com-
pared to NP mice at pregnancy day 12 (Fig. 4a–c). The adoptive transfer of Tregs, which leads to more 
uMCs, normalized sFlt-1 expression (Fig. 4a–c). The same was observed for AT2 (Fig. 4d,e).
Discussion
It is widely accepted that major changes at cellular and molecular levels take place in the uterus immedi-
ately after fecundation. These dramatic changes allow implantation and support the embryo development 
and growth. Mouse models are of importance as they can be employed to study the effect of a particu-
lar cell type or of cell-cell interactions. Here, we are particularly interested in the possible interaction 
between Tregs and MCs as both are of pivotal importance for pregnancy albeit their main functions differ 
greatly. To the best of our knowledge, no studies addressed the possible interaction or interdependence 
between MCs and Tregs during pregnancy.
Figure 2. Transfer of Tregs into abortion-prone mice is related with increase of MC numbers and 
reduction of fetal death rate. (a) Fetal death rates were determined at day 12 of pregnancy in normal 
pregnant (NP, n = 9), abortion-prone (AP, n = 9) and Treg-treated abortion-prone (AP+ Treg, n = 9)  
animals. (b) Representative pictures of uteri of NP, AP and AP + Treg are shown. Arrows indicates 
abortions. The percentage of CD4+Foxp3+ positive cells in (c) decidua (d) thymus and (e) spleen as well as 
the percentage of CD117+Fcε Rα + positive cells in (f) decidua, (g) oviduct and (h) spleen was analyzed by 
flow cytometry at day 12 of pregnancy. (i) Mcpt-1 mRNA levels were analyzed by real time PCR and the 
data expressed as 2−ΔcT. Data are shown as single values with medians. Statistically significant values are 
indicated as follows: *p < 0.054, **p < 0.005, ***p < 0.001 (Mann Whitney-U test).
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Our findings demonstrate that the adoptive transfer of Tregs during early pregnancy influences MCs 
and this in turn is related to improved SA remodeling and increased placenta size. Interestingly, low lev-
els of Tregs have previously been reported in AP vs NP mice during early pregnancy19,30–33. Our results 
confirm and extend these reports as we also found low numbers of CD4+Foxp3+ Tregs in AP mice in 
different immune-related organs as well as in decidua.
Thus, low Treg numbers correlate with low uMC numbers in animals whose pregnancies do not 
progress optimally. In AP animals, not only a higher fetal death rate could be observed but also a defec-
tive placentation. This could explain why Girardi and colleagues observed intrauterine growth restric-
tion (IUGR) in fetuses from this combination34. We next transferred Tregs into AP mice. Successful 
transfer of Tregs was confirmed by detection of significant upregulation of CD4+FoxP3+ cells in organs 
from AP + Treg animals in comparison to the AP group. Decidual Treg levels were also augmented. 
As expected19, Treg transfer resulted in a reduction of the fetal death rate. When analyzing surviving 
fetuses and placentas, we observed that Treg transfer was able to normalize both, placenta size and the 
shaping of SAs. Interestingly, Treg transfer into AP mice was accompanied by a simultaneous increase 
of MC numbers in particular of uMCs as well as increased transcript levels of MC-specific protease 1. 
This strongly suggests a Treg-induced upregulation and activation of MCs at the feto-maternal interface. 
Furthermore, the blockage of IL-10, the major Treg mediator in this model30, hindered Mcpt1 augmen-
tation. Evidence of possible Treg-MC interaction can be found in different models in the literature. For 
example, Lu and colleagues postulated in 2006 that MCs are essential intermediaries in Treg-dependent 
Figure 3. Transfer of Tregs results in elevated numbers of MCs in abortion-prone mice and rescues 
placental and spiral artery defects. Normal pregnant (NP, n = 5), abortion-prone (AP, n = 6) and abortion-
prone animals transferred with Tregs (AP + Treg, n = 7) were sacrificed at day 12 of pregnancy. 5 μ m cross 
sections of paraffin embeeded whole implantation sites (WIS) were stained with H/E. (a) Placental surface 
areas were measured in WIS from NP, AP and AP + Treg mice. The results are presented as single values with 
medians. 1 placenta was measured for each female and the median was calculated for the group. Statistical 
differences were obtained using non-parametric Mann-Whitney-U- test (*p < 0.054). (b) Representative 
pictures (magnification × 10) of Hematoxylin/Eosin stained sections from NP, AP and AP + Treg mice are 
shown. Broken lines indicate the placenta areas. Spiral artery (SA) wall and lumen diameters of 2 to 10 SAs 
per animal of NP (n = 5), AP (n = 6) and AP + Treg (n = 7) were measured and calculated as (c) wall 
thickness and (d) wall/lumen ratio. Data are expressed as mean ± SEM and their statistical significance was 
analyzed by unpaired t-test (*p < 0.054). Representative images of H/E-stained sections (magnification × 400) 
and immunofluorescence for smooth muscle actin and smooth muscle actin + DAPI (magnification × 1000) 
in SA of NP, AP and AP + Treg mice are depicted in (e) (scale bar = 20 μ m).
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tolerance, where IL-9 represents the functional link between the two immune cell populations20. This is 
in agreement with findings reported by Eller and colleagues that suggest that IL-9 production by Tregs 
recruits and activates MCs35. The augmentation in MC numbers after transfer of Tregs in AP mice was 
not linked to increased IL-9 at the feto-maternal interface. In our model the transfer of Treg was rather 
associated with an increase of IL-3 and mSCF at the feto-maternal interface. As both are proposed as 
MC growth factors36–38, it is tempting to speculate that Treg act by augmenting these two mediators. In 
the subsequent studies, we will concentrate on dissecting the factors that are involved in the interaction 
between these two cell types; this is currently not possible due to the technical limitations.
A crucial event in fetal development is a correct placentation. Defects in placentation can cause 
miscarriage or pregnancy diseases like pre-eclampsia or IUGR39. Here, we found that placentas from 
DBA/2J-mated CBA/J females are decreased in size as compared to NP BALB/c-mated CBA/J females. 
This is in agreement with reports claiming that the CBA/J × DBA/2J model represents a valid IUGR 
model as fetuses grow slower in this combination compared to the CBA/J × BALB/c controls34,40. Our 
data show that Treg transfer was able to normalize placenta size. This in turn correlated with an augmen-
tation of the numbers of uMCs. Several studies have linked MCs with placentation6,41–43 but as of yet no 
studies have shown that Tregs are relevant in this context. In contrast, several previous reports indicate 
that Tregs are relevant for implantation17,44,45 and for maintaining immune tolerance30,46. Our results 
suggest that Tregs promote the expansion of uMCs, which in turn positively influences placentation.
To ensure an adequate supply of the fetus with nutrients and oxygen, enough maternal blood has to 
flow to the fetal side. Here, SAs overtake a central role; as pregnancy advances they change their shape 
to turn into thin-walled venous-like vessels. This process is called SA remodeling and is induced by the 
selective reduction of the SM layer11. Insufficient remodeling is linked to pre-eclampsia, fetal growth 
restriction, miscarriage and preterm birth2,47–49. We observed insufficiently remodeled SAs in AP mice; 
this is indicated by an augmented wall thickness and an increased wall-to-lumen ratio when compared to 
the NP mice. Immunohistochemically, we found a thicker SM actin layer that indicates a poor apoptosis 
of this layer. Interestingly, the transfer of Tregs, associated with uMC expansion could normalize both 
wall thickness and wall to lumen ratio. The SM actin layer was comparable to NP mice. Usually, uMCs 
are located close to vessels6 as we could confirm here. Functionally, uMCs are able to modulate a proper 
SA remodeling as we reported for MC-deficient KitW-sh/W-sh animals that were reconstituted with MCs6. 
It was reported that animals depleted of Tregs during pregnancy showed insufficiently remodeled SAs18. 
Whether this was a sole effect of Treg absence or depended on other cells was not further explored in the 
mentioned study. We propose that the transfer of Tregs into AP mice promotes the expansion of uMCs 
and they in turn promote the remodeling of SAs.
Figure 4. Expression of placental sFlt-1 and AT2 in abortion prone mice is normalized after transfer 
of Tregs. The protein levels of the two pregnancy-relevant isoforms of soluble Flt-1 (a) (60 kDa) and (b) 
(145 kDa) as well as (d) angiotensin receptor II (AT2) were analyzed in placental tissue of normal pregnant 
(NP, n = 7), abortion-prone (AP, n = 9) and abortion-prone animals treated with Tregs (AP+ Treg, n = 9) 
by Western blot and expressed as arbitrary units. The data are expressed as medians and analysed by 
Mann- Whitney-U test: p < 0.054, **p < 0.005, ***p < 0.001(Mann-Whitney-U test). (c) Representative blots 
for soluble Flt-1 and (e) AT2 are shown together with the housekeeping genes beta actin (for sFlt-1) and 
GAPDH (for AT2).
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A successful pregnancy depends on a well-balanced angiogenesis/vasculogenesis system. This is medi-
ated by a broad array of angiogenic factors including the interaction between vascular endothelial growth 
factor (VEGF) and its receptor VEGFR. Elevated levels of the soluble form of VEGFR, namely sFlt-1, 
are associated with pregnancy complications including pre-eclampsia12. This is due to the fact that sFlt-1 
inhibits the mandatory VEGF response by forming a complex with VEGF in the circulation50. In the 
presence of elevated sFlt-1, the positive angiogenic influence of VEGF at the fetal-maternal interface 
on placental development and SA formation is impaired. Here, we showed that AP mice, which have 
impaired placentation and insufficient SA remodeling, exhibit significant elevated sFlt-1 levels. In line 
with this, a study from 2006 demonstrated significantly decreased free VEGF levels in AP mice in con-
trast to NP mice34. The same could be shown for sFlt-140. The adoptive transfer of Tregs and the sub-
sequent upregulation of MCs at the feto-maternal interface are associated with downregulated levels of 
sFlt-1; this may explain why placentation is restored, SAs properly remodeled, and fewer fetuses died.
The renin-angiotensin-aldosterone pathway is one of the most important blood pressure-regulating 
systems of the body. Angiotensin (Ang) II is generated from AngI through the activity of 
angiotensin-converting enzyme (ACE) and involved in vascular adaptions and diseases51. Several studies 
have demonstrated that MC chymase is able to generate AngII from AngI independently of ACE52,53. 
Girardi and colleges reported that AP mice show a higher sensitivity to AngII as AngII treatment in 
DBA/2J-mated CBA/J females lead to a significant change in blood pressure. Without application of 
AngII there were no differences between the groups. These observations suggest that the local systems of 
the AP model may serve to increase the effects of circulating AngII by upregulating the AngII receptor34. 
We found that AP mice present upregulated levels of AngII receptor. Transfer of Treg and increase of 
uMCs was related with downregulation of AngII receptor to the levels observed in NP mice, suggesting 
that Treg or uMCs secrete molecules that control the expression of the receptor. Upregulation of the 
AngII receptor at the fetal-maternal interface of pregnant females from the CBA/J × DBA/2J combi-
nation may maintain the signal strength of AngII – AngII receptor as compensation for lower AngII 
concentrations due to decreased MC levels. The chymase AngII generating system is different from the 
ACE-dependent AngII generating system. Tissue originated renin generates Angiotensinogen I from 
Angiotensinogen. Generation of AngII from AngI depends on chymase, which is secreted from the 
granules of MCs. Chymase-dependent AngII does influence tissue remodeling; it is however not involved 
in the regulation of hypertension54. This would explain the insufficient remodeling of SAs in AP mice 
in the absence of elevated systemic blood pressure. In other models, in which SA remodeling is rather 
controlled by uNKs, the insufficient remodeling of SA is directly related with maternal hypertension2.
The data obtained in our study unravel a so far unsuspected cellular interaction that contributes to 
pregnancy maintenance. We show that the adoptive transfer of Tregs to animals that reject their fetuses 
is accompanied by an augmentation of the number of uMCs while having positive effects on placentation 
and the remodeling of SAs, all together leading to healthy fetuses. The mechanisms behind the positive 
effect of Treg and MC crosstalk at the fetal maternal interface include the maintenance of angiogenesis 
balance, especially the normalization of sFlt-1 as well as the modulation of receptors for angiotensin. Our 
study reveals a further aspect of Treg action during pregnancy and highlights the interaction between 
the innate and adaptive immune system with the final goal of supporting pregnancy and fetal growth.
Materials and Methods
Animals. The present study was approved by the German Ministry (203.h-42502-2-868 Magdeburg, 
Landesverwaltungsamt, Halle) and carried out according to institutional guidelines and the Guide for the 
Care and Use of Agricultural Animals in Agricultural Research and Teaching, USA.
The stage of the estrous cycle of sexually mature CBA/J females was determined based on the typical 
cell content of the fresh vaginal lavage with 0.9% sodium chloride. Females were sacrificed when the 
stage was clearly defined. To confirm the stage, samples were stained with hematoxylin/eosin (H/E) and 
analyzed by light microscopy (Axio Observer.A1, Zeiss; magnification × 200).
Female CBA/J (H2k), male DBA/2J (H2d) and male BALB/c (H2d) mice were purchased from Charles 
River (Germany) and Janvier (France). Animals were maintained in the institute’s own barrier animal 
facility with a light/dark cycle of 12/12 h. Female CBA/J mice were mated either with BALB/c males 
(normal pregnant, NP) or DBA/2J males (abortion-prone, AP). Successful mating was confirmed by the 
detection of a vaginal plug. The day of plug detection was considered as day 0 of pregnancy and females 
were separated from the males. CBA/J females were sacrificed on days 0, 2, 5 or 12 of pregnancy. The 
number of animals included in each group and of samples used for each analysis is depicted in the Figure 
legends.
Isolation and Transfer of Tregs. Tregs were isolated from the spleens and lymph nodes (inguinal, 
para-aortic) of normal pregnant females on day 14 of pregnancy as described elsewhere19,30. 2 × 105 cells 
were diluted in 200 μ l PBS and injected intravenously into DBA/2J-mated CBA/J females at day 0 of preg-
nancy. Control animals received PBS. In a further experiment, we used samples from animals that have 
received Treg following the same protocol and were additionally treated with 1 mg of anti-IL-10 mAb at 
days 0 and 7 of pregnancy30. Controls received either Treg alone or Treg + 1 mg IgG30. The abortion rates 
in the groups was as follows: median of abortion: 0.00 for AP + Treg; 10.55 for AP+ IgG+ Treg and 33.31 
for AP + anti-IL-10 + Treg.
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Sample collection and histology. Uterine horns from animals at different phases of the estrous 
cycle, or gd 0, 2 or 5 were dissected, fixed in 96% ethanol, embedded in paraffin and cut longitudinally 
into 5 μ m sections. For visualization of uMCs, sections were stained with Toluidine blue dye (0.1% aque-
ous solution). The number of uMCs was calculated per 1 mm2 by using an Eyepiece-micrometer (Zeiss).
One implantation site per female was collected on day 12 of pregnancy for paraffin embedding with 
previous fixation in 4% (w/v) PFA with 0.1 M sucrose (pH 7.4) for 6 h. Placental and decidual tissue were 
washed with PBS, pH 7.40, snap-frozen, and kept at − 80 °C until use for RNA and protein isolation.
Quantitative histological measurements. The measurements of placental surface areas were per-
formed according to Croy and colleagues55. Briefly, 5 μ m transversal cross sections of feto-placental units 
at day 12 of pregnancy were stained with H/E and the software AxioVision4 (Zeiss) was used to measure 
the placental surface areas at a X10 magnification. The quantitative measurements of SAs were performed 
as described elsewhere53. Shortly, the SA wall and lumen diameters were measured and/or expressed as 
wall to lumen ratios and wall thickness.
Immunofluorescence. Heat induced antigen retrieval of transversal cross-sections of feto-placental 
units was carried out in 10 mmol/l Tris/1mmol/l EDTA buffer (pH 6.0) for 10 min in the microwave. 
Incubation with anti-smooth muscle actin (Dako) was done overnight at 4 °C followed by an AF555 
conjugated secondary antibody (Invitrogen) for 1 h at room temperature. VECTASHIELD mounting 
medium containing DAPI (VECTOR laboratories) was used to counterstain DNA.
Flow Cytometry. Tissue from spleen, thymus, lymph nodes (inguinal, mesenteric and para-aortic) 
and oviducts were processed as described elsewhere19. Uterine tissue was enzymatically digested using 
Liberase TL (Roche). Cells were stained with the following antibodies: FITC-conjugated anti-Fcε RIα , 
PE-conjugated anti-CD117, PerCP-CyTM5.5-conjugated anti-CD4, Alexa Fluor 647-conjugated anti-Foxp3. 
Besides the Fcε RIα antibody (eBioscience) all antibodies were purchased from Becton Dickinson (BD).
Real Time Reverse Transcriptase Polymerase Chain Reaction (RT-PCR). Total RNA isolation 
from frozen decidual tissue was performed by using Trizol (Gibco) and a homogenizer (Ultra Turrax 
T8). The RNA was extracted with chloroform, precipitated with isopropanol, washed in 80% ethanol, 
and finally diluted in RNase-free water. RNA quantity and quality was determined by ultraviolet absorb-
ance at 260 nm. Total RNA (2 μ g) was initially incubated with oligo dTs (Amersham) for 10 min at 75 °C 
followed by 5 min incubation on ice. Subtracted mRNA was than incubated with dNTPs (2.5 mmol/L, 
Amersham), DNase I (2 U/ml, Stratagene) and RNase inhibitor (40 U/ml, Promega) in reaction buffer. 
The mixture was incubated for 30 min at 37 °C and afterwards heated for 5 min at 75 °C. Reverse tran-
scriptase (200 U/ml, Promega) and RNase inhibitor in RNase-free water was added to the mixture and 
incubated at 42 °C for 60 min. Incubation at 94 °C for 5 min followed.
Real-time polymerase chain reaction (RT-PCR) amplifications were performed in an iCycler (BioRad). 
Beta-actin or GAPDH were used as housekeeping genes. Experiments were run in duplets. Amplification 
reactions were performed as follows: initial denaturation at 95 °C for 5 min followed by 40 cycles of 
denaturation at 95 °C for 45 sec and annealing at either 56 °C or 60 °C for 60 sec.
SDS page, Western blot. During and after sonication placental tissue was incubated in lysis buffer 
(10% NP-40, 0.1 mg/ml n-Dodecil-β -D-maltoside, 500 mM sodium fluoride, 10 mM Sodium metavana-
date, 100 mM PMSF, 1M Tris, 0.5 M EDTA, 5 M NaCl) for 60 min. Afterwards cells were centrifuged, 
supernatants were collected and stored overnight at − 80 °C. Protein content was determined by Bradford 
assay (BioRad) as indicated by the manufacturers. Proteins (50 μ g) were resolved on a 8% or 12% 
SDS-PAGE at 100 V and transferred onto a 0.45 μ m nitrocellulose membrane in transfer buffer containing 
20%(v/v) methanol, 0.19 M glycine and 0.025 M Tris (pH 8.3) at a constant voltage on ice. After blocking 
nonspecific-binding sites with 5% (w/v) skim milk powder in TBS with 0.05% (v/v) Tween for 1 h, blots 
were incubated using the following antibodies: Flt-1 (C-17, 1:250, Santa Cruz), AT2 (H-143, 1:500, Santa 
Cruz), β -actin (AC-15, 1:10000, Sigma-Aldrich), GAPDH (FL-335, 1:10000, Santa Cruz). The expression 
of sFlt-1 (two relevant isoforms for pregnancy) was analyzed by using the program GeneTools (SynGene) 
and was referred to β -actin. The expression of AT2 (41 kDa) was referred to GAPDH.
Data analysis and statistics. GraphPad Prism 5.0 software was used for statistical analysis. The 
Shapiro-Wilk test was applied to determine whether or not the values follow a normal distribution. 
Data obtained by flow cytometry and PCR among all groups were calculated by the non-parametric 
Kruskal-Wallis test followed by the Mann-Whitney-U test to calculate the difference between two 
independent groups. Quantification of uterine MCs per 1 mm2 was done by calculating the mean MC 
number at different areas of the uterus. Groups were compared by the unpaired t-test. For histolog-
ical measurements, two to ten SAs per female were measured by AxioVision4 (Zeiss), the mean was 
calculated, and the differences between the animal groups analyzed using unpaired t-test; differences 
regarding the placental surface areas between the groups (1 to 2 placentas/female/group) were analyzed 
by Mann-Whitney-U test. For all tests, P value < 0.054 was considered to be statistically significant. The 
www.nature.com/scientificreports/
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number of animals or samples used for a determined experiment as well as the statistical test used and 
the P values obtained are indicated in each Figure legend.
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